Clinical Trial Update: Study to Assess the Safety of Treatment of Articular Cartilage Lesions With CartiLife® [Phase 1]

View source ↗

Summary

Phase 1 safety study of CartiLife for articular cartilage lesions of the knee has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Knee

Drugs mentioned

• CartiLife

Snippet

Sponsor: Biosolution Co., Ltd. | Conditions: Articular Cartilage Lesion of Knee | Phase 1 | Status: COMPLETED